Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion type Assertion NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_head.
- NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion description "[Further studies of the AQP3, CASP14, ALOX12B, and CLDN1 contributions to chemoresistance may assist in developing novel microRNA-based therapies for human SCC.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_provenance.
- NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion evidence source_evidence_literature NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_provenance.
- NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion SIO_000772 24070899 NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_provenance.
- NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion wasDerivedFrom befree-20140225 NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_provenance.
- NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_assertion wasGeneratedBy ECO_0000203 NP662627.RAGKuZZy4fpZvWy1cbKFplxr2Zz2jmaDkBVsgii980z8w130_provenance.